Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
betrixaban (bevyxxa) (1 trial)
warfarin (coumadin) (1 trial)
Atrial Fibrillation (Phase 2)
Trials (1 total)
Trial APIs (2 total)